ReviewCells2021

OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.

Richard E Kast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.